State of Medical Cannabis Education in the EU and the World

Gregor Zorn
The European Cannabinoid Therapy Association
Countries all around the world are adopting new medical cannabis laws, mainly due to the increasing number of patients using cannabis for therapeutic purposes. These patients should rely on medical professionals to guide them on the various aspects of using medical cannabis preparations. More often than not, patients are facing difficulties in receiving reliable information form medical professionals, as they are lacking the fundamental knowledge on this subject.

This is mainly due to the fact that medical cannabis is not being taught at universities and collages and most physicians feel unprepared to provide reliable information to their patients.  They also have concerns regarding the legal issues, indications, adverse reactions, dosing, and other important aspects of cannabinoid therapy. Most physicians also don’t know about the endogenous cannabinoid system and its important role in health and disease.

To overcome this knowledge gap, specific courses, seminars and conferences, on medical cannabis, are being offered by different organizations. Medical professionals can get the information they need, to feel more comfortable in using cannabinoid therapy for their patients. To avoid these knowledge inconsistencies, the fundamentals of the endocannabinoid system should be integrated in the curriculum of teaching institutions as well as specific medical cannabis courses, for those interested in learning more about this important topic.